1. GPCR/G Protein Neuronal Signaling Membrane Transporter/Ion Channel
  2. mAChR Adrenergic Receptor Calcium Channel
  3. CHF-6366

CHF-6366 是一种有效的 M3 毒蕈碱 (muscarinic) 拮抗剂和 β2 肾上腺素能受体 (adrenergic receptors) 激动剂,pKi 分别为 10.4 和 11.4。CHF-6366 也是一种弱钙离子通道 (calcium channel) 抑制剂 (IC50~50 μM)。CHF-6366 抑制豚鼠的支气管收缩。CHF-6366 可用于慢性阻塞性肺疾病 (COPD) 的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

CHF-6366 Chemical Structure

CHF-6366 Chemical Structure

CAS No. : 1615208-41-7

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

CHF-6366 is a potent M3 muscarinic antagonist and β2-adrenergic receptors agonist with pKi values of 10.4 and 11.4, respectively. CHF-6366 is also a weak calcium channel inhibitor (IC50~50 μM). CHF-6366 inhibits bronchoconstriction in guinea pigs. CHF-6366 can be used to research chronic obstructive pulmonary disease (COPD)[1].

IC50 & Target

pKi: 10.4 (M3 muscarinic receptor), 11.4 (β2-adrenergic receptors)[1]
IC50: ~50 μM (calcium channel)[1]

体内研究
(In Vivo)

CHF-6366 (0.3 and 1 nM/kg; intratracheal administration; single dosage) inhibits bronchoconstriction in a dose-dependent manner[1].
CHF-6366 (500 nM/kg; intratracheal administration; single dosage) exhibits low systemic exposure and no accumulation risk[1].
Pharmacokinetic Parameters of CHF-6366 in lung and plasma of guinea pig (intratracheal administration, 500 nM/kg)[1].

Lung Plasma
Cmax 28400 ng/g 126 ng/mL
Tmax 0.083 h 0.083 h
AUClast 460361 ng/g·h 460 ng/mL·h
AUCinf 725199 ng/g·h 661 ng/mL·h
half-life 49.2 h 15.4 h

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Guinea pigs[1]
Dosage: 0.3 and 1 nM/kg
Administration: Intratracheal administration; single dosage
Result: Inhibited bronchoconstriction in a dose-dependent manner.
Animal Model: Guinea pigs[1]
Dosage: 500 nM/kg (Pharmacokinetic Analysis)
Administration: Intratracheal administration; single dosage
Result: Sustained exposure up to 72 h and the appropriate gradual decline which is suggestive of no accumulation risk.
Showed very low systemic exposure.
Clinical Trial
分子量

764.87

Formula

C42H48N6O8

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
CHF-6366
目录号:
HY-151198
需求量: